Sinopharm Group Co Ltd

1099.HK · Health Services · Medical/Nursing Services · CN

93,764 employees · sinopharmgroup.com.cn

About

Sinopharm Group Co Ltd is one of the largest Chinese companies in the healthcare industry and was founded in 1998. With its headquarters in Beijing, it has been a significant player in the global healthcare sector for many years and operates in various business areas. The company's history dates back to the 1940s when the original company, China National Pharmaceutical Industry Corporation, was founded. It was later transformed into China National Pharmaceutical Group and eventually renamed Sinopharm Group. Sinopharm's business model is designed to promote healthcare in China while expanding internationally. The company's key business areas include pharmaceutical research and development, drug manufacturing, and the import and export of pharmaceutical products. Overall, Sinopharm Group operates in various sectors, including the production of biological drugs, diagnostic products, medical devices, and medical consumables. Additionally, the company is involved in providing healthcare services such as hospital management and health tourism. An important part of Sinopharm's business is the export of drugs and other medical products. The company has established a global presence and maintains businesses and collaborations with companies in Asia, Europe, North America, and Africa. Furthermore, Sinopharm Group has established several subsidiaries to focus on specialized markets and products better. On the product side, Sinopharm offers a wide range of medications, health products, and medical devices. Some of the most well-known products include anti-cancer drugs, diabetes medications, vaccines, and blood products. The company also invests in research and development of new drugs and is involved in numerous clinical trials. The success of Sinopharm is also based on its close collaboration with the Chinese government. The company works closely with local and national authorities to meet the demand for healthcare products and services in China. The Chinese government also supports the company and promotes its expansion into other countries. Overall, Sinopharm Group has become a significant player in the global healthcare industry in recent years. The company has a strong presence in China and a growing international presence. With a wide range of products and services and a strong focus on research and development, Sinopharm Group is well-positioned to continue growing and adapting to the demands of the healthcare sector.

Annual results

Reported figures, CNY · revenue down 1.6% in 2025

YearRevenueNet incomeNet marginFree cash flow
2025669B8.3B1.2%—
2024680B8.2B1.2%—
2023694B10.5B1.5%—
2022643B9.9B1.5%—
2021606B9.0B1.5%—

Dividends per share

2026 0.68 CNY2025 0.74 CNY2024 0.96 CNY2023 0.90 CNY2022 0.87 CNY

1099.HK in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Sinopharm Group Co Ltd are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Sinopharm Group Co Ltd (1099.HK) — company profile and financials · MarketPulse